Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Liver Cirrhosis

  Free Subscription


Articles published in Dig Dis Sci

Retrieve available abstracts of 177 articles:
HTML format



Single Articles


    July 2021
  1. CULLARO G, Rubin JB, Fortune BE, Crawford CV, et al
    Association Between Kidney Dysfunction Types and Mortality Among Hospitalized Patients with Cirrhosis.
    Dig Dis Sci. 2021 Jul 22. pii: 10.1007/s10620-021-07159.
    PubMed     Abstract available


    June 2021
  2. DELEURAN T, Watson H, Vilstrup H, Jepsen P, et al
    Risk Factors for Hepatic Hydrothorax in Cirrhosis Patients with Ascites - A Clinical Cohort Study.
    Dig Dis Sci. 2021 Jun 30. pii: 10.1007/s10620-021-07134.
    PubMed     Abstract available


  3. FRENETTE CT, Levy C, Saab S
    Hepatic Encephalopathy-Related Hospitalizations in Cirrhosis: Transition of Care and Closing the Revolving Door.
    Dig Dis Sci. 2021 Jun 24. pii: 10.1007/s10620-021-07075.
    PubMed     Abstract available


  4. HA NB, Cho SJ, Mohamad Y, Kent D, et al
    Visceral Adipose Tissue Inflammation and Radiographic Visceral-to-Subcutaneous Adipose Tissue Ratio in Patients with Cirrhosis.
    Dig Dis Sci. 2021 Jun 16. pii: 10.1007/s10620-021-07099.
    PubMed     Abstract available


  5. DAHIYA M, Eboreime E, Hyde A, Rahman S, et al
    International Classification of Diseases Codes are Useful in Identifying Cirrhosis in Administrative Databases.
    Dig Dis Sci. 2021 Jun 6. pii: 10.1007/s10620-021-07076.
    PubMed     Abstract available


    May 2021
  6. CACCAMO G, Franze MS, Saffioti F, Pitrone C, et al
    Cirrhotic Patients with Bacterial Infection and Negative Cultures Have a More Advanced Disease and an Increased Short-Term Mortality Rate.
    Dig Dis Sci. 2021 May 26. pii: 10.1007/s10620-021-07047.
    PubMed     Abstract available


  7. PINYOPORNPANISH K, Al-Yaman W, Dasarathy S, Romero-Marrero C, et al
    Hepatocellular Carcinoma in Patients Without Cirrhosis: The Fibrosis Stage Distribution, Characteristics and Survival.
    Dig Dis Sci. 2021 May 23. pii: 10.1007/s10620-021-07048.
    PubMed     Abstract available


  8. SERPER M
    Monitoring for Ascites in Cirrhosis Using Patient-Generated Health Data: No Longer a Remote Possibility.
    Dig Dis Sci. 2021 May 18. pii: 10.1007/s10620-021-07020.
    PubMed    


  9. BLOOM PP, Ventoso M, Tapper E, Ha J, et al
    A Telemonitoring Intervention for Cirrhotic Ascites Management Is Cost-Saving.
    Dig Dis Sci. 2021 May 6. pii: 10.1007/s10620-021-07013.
    PubMed     Abstract available


    March 2021
  10. MAHMUD N, Asrani SK, Reese PP, Kaplan DE, et al
    Race Adjustment in eGFR Equations Does Not Improve Estimation of Acute Kidney Injury Events in Patients with Cirrhosis.
    Dig Dis Sci. 2021 Mar 24. pii: 10.1007/s10620-021-06943.
    PubMed     Abstract available


    January 2021
  11. BALDIN C, Piedade J, Guimaraes L, Victor L, et al
    CLIF-C AD Score Predicts Development of Acute Decompensations and Survival in Hospitalized Cirrhotic Patients.
    Dig Dis Sci. 2021 Jan 3. pii: 10.1007/s10620-020-06791.
    PubMed     Abstract available


  12. HSU CY, Parikh ND, Huo TI, Tapper EB, et al
    Comparison of Seven Noninvasive Models for Predicting Decompensation and Hospitalization in Patients with Cirrhosis.
    Dig Dis Sci. 2021 Jan 2. pii: 10.1007/s10620-020-06763.
    PubMed     Abstract available


    November 2020
  13. O'LEARY JG, Rajender Reddy K, Tandon P, Biggins SW, et al
    Increased Risk of ACLF and Inpatient Mortality in Hospitalized Patients with Cirrhosis and Hepatic Hydrothorax.
    Dig Dis Sci. 2020 Nov 13. pii: 10.1007/s10620-020-06677.
    PubMed     Abstract available


  14. NAYMAGON L, Tremblay D, Zubizarreta N, Moshier E, et al
    Safety, Efficacy, and Long-Term Outcomes of Anticoagulation in Cirrhotic Portal Vein Thrombosis.
    Dig Dis Sci. 2020 Nov 5. pii: 10.1007/s10620-020-06695.
    PubMed     Abstract available


  15. ABY ES, Pham NV, Yum JJ, Dong TS, et al
    Frailty Does Not Impact Caregiver Burden in Patients with Cirrhosis.
    Dig Dis Sci. 2020 Nov 2. pii: 10.1007/s10620-020-06687.
    PubMed     Abstract available


  16. CHEN HW, Ferrando A, White MG, Dennis RA, et al
    Home-Based Physical Activity and Diet Intervention to Improve Physical Function in Advanced Liver Disease: A Randomized Pilot Trial.
    Dig Dis Sci. 2020;65:3350-3359.
    PubMed     Abstract available


    October 2020
  17. MUNOZ AE, Pollarsky F, Marino M, Cartier M, et al
    Safety of Chronic Simvastatin Treatment in Patients with Decompensated Cirrhosis: Many Adverse Events but No Liver Injury.
    Dig Dis Sci. 2020 Oct 9. pii: 10.1007/s10620-020-06630.
    PubMed     Abstract available


    September 2020
  18. TRIEU H, Patel A, Wells C, Saab S, et al
    Disparities in Mortality and Health Care Utilization for 460,851 Hospitalized Patients with Cirrhosis and Hepatic Encephalopathy.
    Dig Dis Sci. 2020 Sep 14. pii: 10.1007/s10620-020-06582.
    PubMed     Abstract available


  19. SIMONS-LINARES CR, Abushamma S, Romero-Marrero C, Bhatt A, et al
    Clinical Outcomes of Acute Pancreatitis in Patients with Cirrhosis According to Liver Disease Severity Scores.
    Dig Dis Sci. 2020 Sep 6. pii: 10.1007/s10620-020-06575.
    PubMed     Abstract available


  20. SHAW J, Patidar KR, Reuter B, Hajezifar N, et al
    Focused Education Increases Hepatocellular Cancer Screening in Patients with Cirrhosis Regardless of Functional Health Literacy.
    Dig Dis Sci. 2020 Sep 5. pii: 10.1007/s10620-020-06583.
    PubMed     Abstract available


  21. PATEL A, Asch S, Antonio AL, Kanwal F, et al
    Measuring the Quality of Palliative Care for Patients with End-Stage Liver Disease.
    Dig Dis Sci. 2020;65:2562-2570.
    PubMed     Abstract available


    August 2020
  22. DENG LX, Mehta N
    Does Hepatocellular Carcinoma Surveillance Increase Survival in At-Risk Populations? Patient Selection, Biomarkers, and Barriers.
    Dig Dis Sci. 2020 Aug 29. pii: 10.1007/s10620-020-06550.
    PubMed     Abstract available


  23. REICHERT MC, Massmann A, Schulz A, Buecker A, et al
    Volume-Function Analysis (LiMAx Test) in Patients with HCC and Cirrhosis Undergoing TACE-A Feasibility Study.
    Dig Dis Sci. 2020 Aug 20. pii: 10.1007/s10620-020-06535.
    PubMed     Abstract available


  24. GRUTTADAURIA S, Pagano D, di Francesco F, Foglio A, et al
    Adult to Adult Living Donor Liver Transplantation in Recipients with Low MELD: A Strategy Intended to Overcome Donor Shortage.
    Dig Dis Sci. 2020 Aug 5. pii: 10.1007/s10620-020-06522.
    PubMed     Abstract available


    July 2020
  25. LE L, Kullar R, Saleh HM, Saab S, et al
    Preferred Noninvasive Testing for Nonalcoholic Steatohepatitis.
    Dig Dis Sci. 2020 Jul 15. pii: 10.1007/s10620-020-06382.
    PubMed     Abstract available


    June 2020
  26. LOUISSAINT J, Foster C, Harding-Theobald E, Lok AS, et al
    Social Support Does Not Modify the Risk of Readmission for Patients with Decompensated Cirrhosis.
    Dig Dis Sci. 2020 Jun 23. pii: 10.1007/s10620-020-06421.
    PubMed     Abstract available


  27. DANFORD CJ, Lee JY, Strohbehn IA, Corey KE, et al
    Development of an Algorithm to Identify Cases of Nonalcoholic Steatohepatitis Cirrhosis in the Electronic Health Record.
    Dig Dis Sci. 2020 Jun 13. pii: 10.1007/s10620-020-06388.
    PubMed     Abstract available


    May 2020
  28. SHROFF H, Rinella ME
    Thanks to CLD for Small Favors: Reduced CVD Risk in Patients Awaiting Liver Transplantation.
    Dig Dis Sci. 2020 May 29. pii: 10.1007/s10620-020-06322.
    PubMed    


  29. LUI FH, Ma P, Helmy M, Hu KQ, et al
    Ultrasonographic (US) Two-Dimensional Measurement of Spleen Is Superior to Traditional Length Measurement Alone in Diagnosing Cirrhosis.
    Dig Dis Sci. 2020 May 23. pii: 10.1007/s10620-020-06332.
    PubMed     Abstract available


  30. FERRARESE A, Burra P, Senzolo M
    A Commentary on the Interplay Between Severity of Liver Disease and Bacterial Infection in Hospitalized Patients with Cirrhosis.
    Dig Dis Sci. 2020 May 8. pii: 10.1007/s10620-020-06278.
    PubMed    


    April 2020
  31. TESTINO G
    Transjugular Intrahepatic Porto Systemic Shunt for Hepatorenal Syndrome in Alcoholic Patients.
    Dig Dis Sci. 2020 Apr 13. pii: 10.1007/s10620-020-06243.
    PubMed    


  32. O'BEIRNE J
    Liver Transplantation for Alcoholic Liver Disease: Absence of Evidence for the Relevance of Abstinence.
    Dig Dis Sci. 2020 Apr 3. pii: 10.1007/s10620-020-06235.
    PubMed    


  33. TURKSEVEN S, Bolognesi M, Di Pascoli M
    Contribution of Splenic Resistance Arteries to Splanchnic Blood Overflow in Cirrhosis.
    Dig Dis Sci. 2020 Apr 2. pii: 10.1007/s10620-020-06233.
    PubMed     Abstract available


  34. TIEN PC, Duarte M, Roque A, Price J, et al
    MRE and ELF in Liver Fibrosis Assessment: Are Two Better Than One?
    Dig Dis Sci. 2020;65:928-930.
    PubMed    


    March 2020
  35. PATEL S, Siddiqui MB, Chandrakumaran A, Rodriguez VA, et al
    Progression to Cirrhosis Leads to Improvement in Atherogenic Milieu.
    Dig Dis Sci. 2020 Mar 18. pii: 10.1007/s10620-020-06196.
    PubMed     Abstract available


  36. O'LEARY JG, Tandon P, Reddy KR, Biggins SW, et al
    Underutilization of Hospice in Inpatients with Cirrhosis: The NACSELD Experience.
    Dig Dis Sci. 2020 Mar 7. pii: 10.1007/s10620-020-06168.
    PubMed     Abstract available


  37. LI J, Dong S, Ye M, Peng G, et al
    MicroRNA-489-3p Represses Hepatic Stellate Cells Activation by Negatively Regulating the JAG1/Notch3 Signaling Pathway.
    Dig Dis Sci. 2020 Mar 7. pii: 10.1007/s10620-020-06174.
    PubMed     Abstract available


  38. ZHANG L, Tai Y, Tang S, Zhao C, et al
    Compromised Ileal Mucus Barrier Due to Impaired Epithelial Homeostasis Caused by Notch1 Signaling in Cirrhotic Rats.
    Dig Dis Sci. 2020 Mar 6. pii: 10.1007/s10620-020-06178.
    PubMed     Abstract available


    February 2020
  39. MELLINGER JL, Stine JG
    Early Liver Transplantation for Severe Alcoholic Hepatitis.
    Dig Dis Sci. 2020 Feb 27. pii: 10.1007/s10620-020-06159.
    PubMed     Abstract available


  40. FRICKER ZP, Mukthinuthalapati VVPK, Akinyeye S, Chalasani N, et al
    MELD-Na Is More Strongly Associated with Risk of Infection and Outcomes Than Other Characteristics of Patients with Cirrhosis.
    Dig Dis Sci. 2020 Feb 25. pii: 10.1007/s10620-020-06164.
    PubMed     Abstract available


  41. AMJAD W, Alukal J, Doycheva I, Zhang T, et al
    A Combination of N-Acetylcysteine and Prednisone Has No Benefit Over Prednisone Alone in Severe Alcoholic Hepatitis: A Retrospective Analysis.
    Dig Dis Sci. 2020 Feb 18. pii: 10.1007/s10620-020-06142.
    PubMed     Abstract available


  42. WONG K, Podboy A, Lavezo J, Goel A, et al
    Dead Meat: Glecaprevir/Pibrentasvir-Induced Statin Myonecrosis.
    Dig Dis Sci. 2020;65:399-400.
    PubMed    


    January 2020
  43. MURPHY SL, Richardson JK, Blackwood J, Martinez B, et al
    Neurocognitive and Muscular Capacities Are Associated with Frailty in Adults with Cirrhosis.
    Dig Dis Sci. 2020 Jan 25. pii: 10.1007/s10620-020-06099.
    PubMed     Abstract available


  44. CHIANG RS, Parish A, Niedzwiecki D, Kappus MR, et al
    Impact of Malnutrition on Outcomes in Patients Undergoing Transjugular Intrahepatic Portosystemic Shunt Insertion.
    Dig Dis Sci. 2020 Jan 21. pii: 10.1007/s10620-019-06038.
    PubMed     Abstract available


  45. SASSO R, Lauzon S, Rockey DC
    Cirrhotic Patients on Mechanical Ventilation Have a Low Rate of Successful Extubation and Survival.
    Dig Dis Sci. 2020 Jan 20. pii: 10.1007/s10620-020-06051.
    PubMed     Abstract available


  46. GUEDES RR, Kieling CO, Dos Santos JL, da Rocha C, et al
    Severity of Ascites Is Associated with Increased Mortality in Patients with Cirrhosis Secondary to Biliary Atresia.
    Dig Dis Sci. 2020 Jan 6. pii: 10.1007/s10620-019-06029.
    PubMed     Abstract available


  47. ZHAO XM, Zhang J, Liang YN, Niu YC, et al
    Astragaloside IV Synergizes with Ferulic Acid to Alleviate Hepatic Fibrosis in Bile Duct-Ligated Cirrhotic Rats.
    Dig Dis Sci. 2020 Jan 3. pii: 10.1007/s10620-019-06017.
    PubMed     Abstract available


  48. ALLEGRITTI M, Enrico B, Basile E, de Vito L, et al
    Non-cirrhotic Extra-Hepatic Porto-Systemic Shunt Causing Adult-Onset Encephalopathy Treated with Endovascular Closure.
    Dig Dis Sci. 2020 Jan 3. pii: 10.1007/s10620-019-06024.
    PubMed     Abstract available


  49. YIK B, Shah N
    Autoconversion of Autoimmune Liver Diseases.
    Dig Dis Sci. 2020;65:71-73.
    PubMed    


  50. ENOMOTO M, Kawada N
    The Moral of Hepatic Fibrosis: Don't Always Believe Noninvasive Fibrosis Measurements.
    Dig Dis Sci. 2020 Jan 1. pii: 10.1007/s10620-019-06035.
    PubMed    


    December 2019
  51. UNGER LW, Forstner B, Muckenhuber M, Scheuba K, et al
    Hepatic Steatosis in Lean Patients: Risk Factors and Impact on Mortality.
    Dig Dis Sci. 2019 Dec 24. pii: 10.1007/s10620-019-06000.
    PubMed     Abstract available


  52. KAPS L, Grambihler A, Yemane B, Nagel M, et al
    Symptom Burden and Treatment Response in Patients with Primary Biliary Cholangitis (PBC).
    Dig Dis Sci. 2019 Dec 18. pii: 10.1007/s10620-019-06009.
    PubMed     Abstract available


    November 2019
  53. CANNON MD, Martin P, Carrion AF
    Bacterial Infection in Patients with Cirrhosis: Don't Get Bugged to Death.
    Dig Dis Sci. 2019 Nov 25. pii: 10.1007/s10620-019-05943.
    PubMed     Abstract available


  54. CHEN Y, Ji H, Shao J, Jia Y, et al
    Different Hepatitis C Virus Infection Statuses Show a Significant Risk of Developing Type 2 Diabetes Mellitus: A Network Meta-Analysis.
    Dig Dis Sci. 2019 Nov 23. pii: 10.1007/s10620-019-05918.
    PubMed     Abstract available


  55. GOUDRA B, Singh PM
    GI Endoscopy Sedation in Patients with Cirrhosis: Routine or Unpredictable?
    Dig Dis Sci. 2019 Nov 13. pii: 10.1007/s10620-019-05949.
    PubMed    


  56. VUYYURU SK, Singh AD, Gamanagatti SR, Rout G, et al
    A Randomized Control Trial of Thromboelastography-Guided Transfusion in Cirrhosis for High-Risk Invasive Liver-Related Procedures.
    Dig Dis Sci. 2019 Nov 13. pii: 10.1007/s10620-019-05939.
    PubMed     Abstract available


  57. HSU PY, Hsu CT, Yeh ML, Huang CF, et al
    Early Fibrosis but Late Tumor Stage and Worse Outcomes in Hepatocellular Carcinoma Patients Without Hepatitis B or Hepatitis C.
    Dig Dis Sci. 2019 Nov 13. pii: 10.1007/s10620-019-05938.
    PubMed     Abstract available


  58. LIANG KH, Zhang P, Lin CL, Wang SC, et al
    Morphomic Signatures Derived from Computed Tomography Predict Hepatocellular Carcinoma Occurrence in Cirrhotic Patients.
    Dig Dis Sci. 2019 Nov 2. pii: 10.1007/s10620-019-05915.
    PubMed     Abstract available


    October 2019
  59. LING C, Khalid S, Martin D, Hanson J, et al
    HCCs and HCAs in Non-cirrhotic Patients: What You See May Not Be Enough.
    Dig Dis Sci. 2019 Oct 30. pii: 10.1007/s10620-019-05920.
    PubMed    


  60. HUANG R, Rao H, Yang M, Gao Y, et al
    Noninvasive Measurements Predict Liver Fibrosis Well in Hepatitis C Virus Patients After Direct-Acting Antiviral Therapy.
    Dig Dis Sci. 2019 Oct 25. pii: 10.1007/s10620-019-05886.
    PubMed     Abstract available


  61. STINE JG, Intagliata NM, Shah NL, Lisman T, et al
    Clinical Cirrhosis Dilemmas: Survey of Practice from the 7th International Coagulation in Liver Disease Conference.
    Dig Dis Sci. 2019 Oct 18. pii: 10.1007/s10620-019-05884.
    PubMed     Abstract available


  62. EDELSON J, Suarez AL, Zhang J, Rockey DC, et al
    Sedation During Endoscopy in Patients with Cirrhosis: Safety and Predictors of Adverse Events.
    Dig Dis Sci. 2019 Oct 12. pii: 10.1007/s10620-019-05845.
    PubMed     Abstract available


  63. ZOU B, Yeo YH, Jeong D, Park H, et al
    A Nationwide Study of Inpatient Admissions, Mortality, and Costs for Patients with Cirrhosis from 2005 to 2015 in the USA.
    Dig Dis Sci. 2019 Oct 9. pii: 10.1007/s10620-019-05869.
    PubMed     Abstract available


    September 2019
  64. KOOLA JD, Ho SB, Cao A, Chen G, et al
    Predicting 30-Day Hospital Readmission Risk in a National Cohort of Patients with Cirrhosis.
    Dig Dis Sci. 2019 Sep 17. pii: 10.1007/s10620-019-05826.
    PubMed     Abstract available


  65. GALOOSIAN A, Hanlon C, Tana M, Cheung R, et al
    Race/Ethnicity and Insurance-Specific Disparities in In-Hospital Mortality Among Adults with Primary Biliary Cholangitis: Analysis of 2007-2014 National Inpatient Sample.
    Dig Dis Sci. 2019 Sep 5. pii: 10.1007/s10620-019-05809.
    PubMed     Abstract available


  66. RAVAIOLI F, Colecchia A
    Sound Conclusions: How Splenic Elastography May Decrease the Need for Endoscopic Variceal Surveillance.
    Dig Dis Sci. 2019;64:2381-2383.
    PubMed    


  67. MA J, Qiu Y, Wang M, Zhang M, et al
    Locostatin Alleviates Liver Fibrosis Induced by Carbon Tetrachloride in Mice.
    Dig Dis Sci. 2019;64:2570-2580.
    PubMed     Abstract available


    August 2019
  68. SHERMAN KE, Abdel-Hameed EA, Ehman RL, Rouster SD, et al
    Validation and Refinement of Noninvasive Methods to Assess Hepatic Fibrosis: Magnetic Resonance Elastography Versus Enhanced Liver Fibrosis Index.
    Dig Dis Sci. 2019 Aug 29. pii: 10.1007/s10620-019-05815.
    PubMed     Abstract available


  69. SAYINER M, Stepanova M, De Avila L, Golabi P, et al
    Outcomes of Liver Transplant Candidates with Primary Biliary Cholangitis: The Data from the Scientific Registry of Transplant Recipients.
    Dig Dis Sci. 2019 Aug 27. pii: 10.1007/s10620-019-05786.
    PubMed     Abstract available


  70. FEUERSTADT P, Hong SJ, Brandt LJ
    Chronic Rifaximin Use in Cirrhotic Patients Is Associated with Decreased Rate of C. difficile Infection.
    Dig Dis Sci. 2019 Aug 22. pii: 10.1007/s10620-019-05804.
    PubMed     Abstract available


  71. WALLACE MC, Sek K, Francis RJ, Samuelson S, et al
    Baseline and Post-treatment 18F-Fluorocholine PET/CT Predicts Outcomes in Hepatocellular Carcinoma Following Locoregional Therapy.
    Dig Dis Sci. 2019 Aug 22. pii: 10.1007/s10620-019-05781.
    PubMed     Abstract available


  72. ALI RO, Moon MS, Townsend EC, Hill K, et al
    Exploring the Link Between Platelet Numbers and Vascular Homeostasis Across Early and Late Stages of Fibrosis in Hepatitis C.
    Dig Dis Sci. 2019 Aug 12. pii: 10.1007/s10620-019-05760.
    PubMed     Abstract available


  73. HAO YL, Bian ZL, Ju LL, Liu Y, et al
    RANK/RANKL Acts as a Protective Factor by Targeting Cholangiocytes in Primary Biliary Cholangitis.
    Dig Dis Sci. 2019 Aug 3. pii: 10.1007/s10620-019-05758.
    PubMed     Abstract available


  74. JOSHI SS, Gao S, Castillo E, Coffin CS, et al
    Presence of Precore (C)/C Promoter Mutants in Peripheral Blood Mononuclear Cells of Chronic Hepatitis B (CHB) Carriers During Pregnancy Does Not Correlate with Increased Risk of Liver Disease in 4 Years of Follow-Up.
    Dig Dis Sci. 2019 Aug 2. pii: 10.1007/s10620-019-05745.
    PubMed     Abstract available


  75. PHAW NA, Jones DEJ
    PBC: Better Solutions to Beat Feeling Beat.
    Dig Dis Sci. 2019;64:2075-2077.
    PubMed    


    July 2019
  76. TAO J, Li J, Chen X, Guo Y, et al
    Endoscopic Variceal Sequential Ligation Does Not Increase Risk of Gastroesophageal Reflux Disease in Cirrhosis Patients.
    Dig Dis Sci. 2019 Jul 22. pii: 10.1007/s10620-019-05740.
    PubMed     Abstract available


  77. SAMJI NS, Verma R, Keri KC, Singal AK, et al
    Liver Transplantation for Nonalcoholic Steatohepatitis: Pathophysiology of Recurrence and Clinical Challenges.
    Dig Dis Sci. 2019 Jul 16. pii: 10.1007/s10620-019-05716.
    PubMed     Abstract available


  78. KUZNIETSOVA HM, Dziubenko NV, Lynchak OV, Herheliuk TS, et al
    Effects of Pristine C60 Fullerenes on Liver and Pancreas in alpha-Naphthylisothiocyanate-Induced Cholangitis.
    Dig Dis Sci. 2019 Jul 16. pii: 10.1007/s10620-019-05730.
    PubMed     Abstract available


  79. TAPPER EB, Derstine B, Baki J, Su GL, et al
    Bedside Measures of Frailty and Cognitive Function Correlate with Sarcopenia in Patients with Cirrhosis.
    Dig Dis Sci. 2019 Jul 10. pii: 10.1007/s10620-019-05713.
    PubMed     Abstract available


    June 2019
  80. KIM DS, Lim TS, Jeon MY, Kim BK, et al
    Transarterial Chemoembolization in Treatment-Naive and Recurrent Hepatocellular Carcinoma: A Propensity-Matched Outcome Analysis.
    Dig Dis Sci. 2019 Jun 11. pii: 10.1007/s10620-019-05701.
    PubMed     Abstract available


  81. MANKA P, Bechmann L, Best J, Sydor S, et al
    Low Free Triiodothyronine Is Associated with Advanced Fibrosis in Patients at High Risk for Nonalcoholic Steatohepatitis.
    Dig Dis Sci. 2019 Jun 3. pii: 10.1007/s10620-019-05687.
    PubMed     Abstract available


  82. CROPLEY A, Ashrafy AH, Weltman M
    An Original Description of Granulomatous Liver Cirrhosis in Blau Syndrome.
    Dig Dis Sci. 2019 Jun 1. pii: 10.1007/s10620-019-05682.
    PubMed    


    May 2019
  83. CORBI LE, Tannuri ACA, de Aro Braz MJ, Paes VR, et al
    Does Biliodigestive Anastomosis Have Any Effect on the Reversal of Hepatopulmonary Syndrome in a Biliary Cirrhosis Experimental Model?
    Dig Dis Sci. 2019 May 10. pii: 10.1007/s10620-019-05658.
    PubMed     Abstract available


  84. ALMANZA D, Gharaee-Kermani M, Zhilin-Roth A, Rodriguez-Nieves JA, et al
    Nonalcoholic Fatty Liver Disease Demonstrates a Pre-fibrotic and Premalignant Molecular Signature.
    Dig Dis Sci. 2019;64:1257-1269.
    PubMed     Abstract available


    April 2019
  85. DEMORROW S
    Concise Commentary: Staying True to Type-The Increasing Inpatient Burden of Hepatic Encephalopathy.
    Dig Dis Sci. 2019 Apr 29. pii: 10.1007/s10620-019-05630.
    PubMed    


  86. KARAGIANNAKIS DS, Voulgaris T, Koureta E, Chloupi E, et al
    Role of Spleen Stiffness Measurement by 2D-Shear Wave Elastography in Ruling Out the Presence of High-Risk Varices in Cirrhotic Patients.
    Dig Dis Sci. 2019 Apr 15. pii: 10.1007/s10620-019-05616.
    PubMed     Abstract available


    March 2019
  87. KOHLI R, Shingina A, New S, Chaturvedi S, et al
    Thromboelastography Parameters Are Associated with Cirrhosis Severity.
    Dig Dis Sci. 2019 Mar 26. pii: 10.1007/s10620-019-05597.
    PubMed     Abstract available


  88. WEI M, Ford J, Li Q, Jeong D, et al
    Correction to: Hospital Cirrhosis Volume and Readmission in Patients with Cirrhosis in California.
    Dig Dis Sci. 2019 Mar 13. pii: 10.1007/s10620-019-05558.
    PubMed     Abstract available


  89. HIRODE G, Vittinghoff E, Wong RJ
    Increasing Burden of Hepatic Encephalopathy Among Hospitalized Adults: An Analysis of the 2010-2014 National Inpatient Sample.
    Dig Dis Sci. 2019 Mar 13. pii: 10.1007/s10620-019-05576.
    PubMed     Abstract available


  90. NORONHA FERREIRA C, Reis D, Cortez-Pinto H, Tato Marinho R, et al
    Anticoagulation in Cirrhosis and Portal Vein Thrombosis Is Safe and Improves Prognosis in Advanced Cirrhosis.
    Dig Dis Sci. 2019 Mar 9. pii: 10.1007/s10620-019-05572.
    PubMed     Abstract available


  91. ROUT G, Sharma S, Gunjan D, Kedia S, et al
    Development and Validation of a Novel Model for Outcomes in Patients with Cirrhosis and Acute Variceal Bleeding.
    Dig Dis Sci. 2019 Mar 4. pii: 10.1007/s10620-019-05557.
    PubMed     Abstract available


    February 2019
  92. ARDOLINO E, Wang SS, Patwardhan VR
    Evidence of Significant Ceftriaxone and Quinolone Resistance in Cirrhotics with Spontaneous Bacterial Peritonitis.
    Dig Dis Sci. 2019 Feb 14. pii: 10.1007/s10620-019-05519.
    PubMed     Abstract available


    January 2019
  93. NEVENS F, Bittencourt PL, Coenraad MJ, Ding H, et al
    Recommendations on the Diagnosis and Initial Management of Acute Variceal Bleeding and Hepatorenal Syndrome in Patients with Cirrhosis.
    Dig Dis Sci. 2019 Jan 25. pii: 10.1007/s10620-018-5448.
    PubMed     Abstract available


  94. BARRITT AS 4TH, Jiang Y, Schmidt M, Hayashi PH, et al
    Charges for Alcoholic Cirrhosis Exceed All Other Etiologies of Cirrhosis Combined: A National and State Inpatient Survey Analysis.
    Dig Dis Sci. 2019 Jan 23. pii: 10.1007/s10620-019-5471.
    PubMed     Abstract available


  95. TANSEL A, Kramer J, Feng H, El-Serag HB, et al
    Risk Trajectories for Readmission and Death After Cirrhosis-Related Hospitalization.
    Dig Dis Sci. 2019 Jan 23. pii: 10.1007/s10620-019-5459.
    PubMed     Abstract available


  96. ZHI SC, Chen SZ, Li YY, Li JJ, et al
    Rosiglitazone Inhibits Activation of Hepatic Stellate Cells via Up-Regulating Micro-RNA-124-3p to Alleviate Hepatic Fibrosis.
    Dig Dis Sci. 2019 Jan 23. pii: 10.1007/s10620-019-5462.
    PubMed     Abstract available


  97. THEOCHARIDOU E, Giouleme O, Anastasiadis S, Markopoulou A, et al
    Free Cortisol Is a More Accurate Marker for Adrenal Function and Does Not Correlate with Renal Function in Cirrhosis.
    Dig Dis Sci. 2019 Jan 19. pii: 10.1007/s10620-019-5460.
    PubMed     Abstract available


  98. LEE KC, Hsu WF, Hsieh YC, Chan CC, et al
    Dabigatran Reduces Liver Fibrosis in Thioacetamide-Injured Rats.
    Dig Dis Sci. 2019;64:102-112.
    PubMed     Abstract available


  99. ROSENBLATT R, Mehta A, Snell D, Hissong E, et al
    Ultrasonographic Nonalcoholic Fatty Pancreas Is Associated with Advanced Fibrosis in NAFLD: A Retrospective Analysis.
    Dig Dis Sci. 2019;64:262-268.
    PubMed     Abstract available


    December 2018
  100. STINE JG, Northup PG
    Management of Non-tumoral Portal Vein Thrombosis in Patients with Cirrhosis.
    Dig Dis Sci. 2018 Dec 17. pii: 10.1007/s10620-018-5427.
    PubMed     Abstract available


  101. KAKAR S, Dugum M, Cabello R, Humar A, et al
    Incidence of Recurrent NASH-Related Allograft Cirrhosis.
    Dig Dis Sci. 2018 Dec 17. pii: 10.1007/s10620-018-5413.
    PubMed     Abstract available


    November 2018
  102. JARA M, Dziodzio T, Malinowski M, Luttgert K, et al
    Prospective Assessment of Liver Function by an Enzymatic Liver Function Test to Estimate Short-Term Survival in Patients with Liver Cirrhosis.
    Dig Dis Sci. 2018 Nov 7. pii: 10.1007/s10620-018-5360.
    PubMed     Abstract available


  103. DE MARIA C, Ghidotti I, Grillo F, Giannini EG, et al
    Successful DAA Treatment and Global Improvement in a Cirrhotic Patient with Concomitant HCV Infection and Autoimmune Hepatitis.
    Dig Dis Sci. 2018 Nov 1. pii: 10.1007/s10620-018-5356.
    PubMed    


    October 2018
  104. CZAJA AJ, Montano-Loza AJ
    Evolving Role of Vitamin D in Immune-Mediated Disease and Its Implications in Autoimmune Hepatitis.
    Dig Dis Sci. 2018 Oct 28. pii: 10.1007/s10620-018-5351.
    PubMed     Abstract available


  105. MURPHY SL, Tapper EB, Blackwood J, Richardson JK, et al
    Why Do Individuals with Cirrhosis Fall? A Mechanistic Model for Fall Assessment, Treatment, and Research.
    Dig Dis Sci. 2018 Oct 16. pii: 10.1007/s10620-018-5333.
    PubMed     Abstract available


    September 2018
  106. YANNY B, Saab S, Durazo F, Latt N, et al
    Eight-Week Hepatitis C Treatment with New Direct Acting Antivirals Has a Better Safety Profile While Being Effective in the Treatment-Naive Geriatric Population Without Liver Cirrhosis and Hepatitis C Virus-RNA < 6 Million IU/mL.
    Dig Dis Sci. 2018 Sep 27. pii: 10.1007/s10620-018-5283.
    PubMed     Abstract available


  107. LEE HM, Ahn J, Kim WR, Lim JK, et al
    A Comparison Between Community and Academic Practices in the USA in the Management of Chronic Hepatitis B Patients Receiving Entecavir: Results of the ENUMERATE Study.
    Dig Dis Sci. 2018 Sep 20. pii: 10.1007/s10620-018-5281.
    PubMed     Abstract available


  108. OU Q, Weng Y, Wang S, Zhao Y, et al
    Silybin Alleviates Hepatic Steatosis and Fibrosis in NASH Mice by Inhibiting Oxidative Stress and Involvement with the Nf-kappaB Pathway.
    Dig Dis Sci. 2018 Sep 6. pii: 10.1007/s10620-018-5268.
    PubMed     Abstract available


  109. PATEL YA, Gifford EJ, Glass LM, Turner MJ, et al
    Identifying Nonalcoholic Fatty Liver Disease Advanced Fibrosis in the Veterans Health Administration.
    Dig Dis Sci. 2018;63:2259-2266.
    PubMed     Abstract available


    August 2018
  110. ADDEPALLY NS, George N, Martinez-Macias R, Garcia-Saenz-de-Sicilia M, et al
    Hemoglobin A1c Has Suboptimal Performance to Diagnose and Monitor Diabetes Mellitus in Patients with Cirrhosis.
    Dig Dis Sci. 2018 Aug 29. pii: 10.1007/s10620-018-5265.
    PubMed     Abstract available


  111. SIKAVI C, Najarian L, Saab S
    Similar Sustained Virologic Response in Real-World and Clinical Trial Studies of Hepatitis C/Human Immunodeficiency Virus Coinfection.
    Dig Dis Sci. 2018 Aug 9. pii: 10.1007/s10620-018-5215.
    PubMed     Abstract available


    July 2018
  112. KALIANNAN K
    Compromise of alpha-Defensin Function in Liver Cirrhosis Facilitates the Toxic Relationship Between Gut Permeability and Endotoxemia.
    Dig Dis Sci. 2018 Jul 14. pii: 10.1007/s10620-018-5197.
    PubMed    


    June 2018
  113. ZHANG S, Gong Y, Xiao J, Chai Y, et al
    A COL1A1 Promoter-Controlled Expression of TGF-beta Soluble Receptor Inhibits Hepatic Fibrosis Without Triggering Autoimmune Responses.
    Dig Dis Sci. 2018 Jun 23. pii: 10.1007/s10620-018-5168.
    PubMed     Abstract available


  114. KIM NH, Cho YK, Kim BI, Kim HJ, et al
    Effect of Metabolic Syndrome on the Clinical Outcomes of Chronic Hepatitis B Patients with Nucleos(t)ide Analogues Treatment.
    Dig Dis Sci. 2018 Jun 12. pii: 10.1007/s10620-018-5165.
    PubMed     Abstract available


  115. TSIAOUSSIS GI, Papaioannou EC, Kourea EP, Assimakopoulos SF, et al
    Expression of alpha-Defensins, CD20+ B-lymphocytes, and Intraepithelial CD3+ T-lymphocytes in the Intestinal Mucosa of Patients with Liver Cirrhosis: Emerging Mediators of Intestinal Barrier Function.
    Dig Dis Sci. 2018 Jun 7. pii: 10.1007/s10620-018-5146.
    PubMed     Abstract available


    May 2018
  116. BAJAJ JS, Ross D
    Concise Commentary: Remaining Outside the Hospital Is a Golden State in Cirrhosis-Lessons from California.
    Dig Dis Sci. 2018 May 30. pii: 10.1007/s10620-018-5134.
    PubMed    


  117. JOPSON L, Khanna A, Peterson P, Rudell E, et al
    Are Clinicians Ready for Safe Use of Stratified Therapy in Primary Biliary Cholangitis (PBC)? A Study of Educational Awareness.
    Dig Dis Sci. 2018 May 8. pii: 10.1007/s10620-018-5074.
    PubMed     Abstract available


  118. WANG P, Li Z, Ren S, Li J, et al
    Spleen Regulates Hematopoietic Stem/Progenitor Cell Functions Through Regulation of EGF in Cirrhotic Hypersplenism.
    Dig Dis Sci. 2018 May 3. pii: 10.1007/s10620-018-5091.
    PubMed     Abstract available


  119. FACCIORUSSO A, Roy S, Livadas S, Fevrier-Paul A, et al
    Nonselective Beta-Blockers Do Not Affect Survival in Cirrhotic Patients with Ascites.
    Dig Dis Sci. 2018 May 3. pii: 10.1007/s10620-018-5092.
    PubMed     Abstract available


  120. NIU B, Kim B, Limketkai BN, Sun J, et al
    Mortality from Spontaneous Bacterial Peritonitis Among Hospitalized Patients in the USA.
    Dig Dis Sci. 2018;63:1327-1333.
    PubMed     Abstract available


    April 2018
  121. GIANNINI EG, Coppo C, Romana C, Camerini GB, et al
    Long-Term Follow-Up Study of Liver-Related Outcome After Bilio-Pancreatic Diversion in Patients with Initial, Significant Liver Damage.
    Dig Dis Sci. 2018 Apr 9. pii: 10.1007/s10620-018-5052.
    PubMed     Abstract available


    March 2018
  122. PONZETTO A, Vaira D
    Hepatic Encephalopathy and Helicobacter pylori.
    Dig Dis Sci. 2018 Mar 29. pii: 10.1007/s10620-018-5038.
    PubMed    


  123. DANIELSEN KV, Wiese S, Hove J, Bendtsen F, et al
    Pronounced Coronary Arteriosclerosis in Cirrhosis: Influence on Cardiac Function and Survival?
    Dig Dis Sci. 2018 Mar 8. pii: 10.1007/s10620-018-5006.
    PubMed     Abstract available


    February 2018
  124. KOUNTOURAS J, Polyzos SA, Katsinelos P, Anastasiadis S, et al
    Potential Impact of Helicobacter Pylori on Hepatic Encephalopathy Pathophysiology.
    Dig Dis Sci. 2018 Feb 21. pii: 10.1007/s10620-018-4911.
    PubMed    


  125. WEI M, Ford J, Li Q, Jeong D, et al
    Hospital Cirrhosis Volume and Readmission in Patients with Cirrhosis in California.
    Dig Dis Sci. 2018 Feb 19. pii: 10.1007/s10620-018-4964.
    PubMed     Abstract available


  126. MAIER MM, Zhou XH, Chapko M, Leipertz SL, et al
    Hepatitis C Cure Is Associated with Decreased Healthcare Costs in Cirrhotics in Retrospective Veterans Affairs Cohort.
    Dig Dis Sci. 2018 Feb 16. pii: 10.1007/s10620-018-4956.
    PubMed     Abstract available


  127. MINDIKOGLU AL, Opekun AR, Mitch WE, Magder LS, et al
    Cystatin C Is a Gender-Neutral Glomerular Filtration Rate Biomarker in Patients with Cirrhosis.
    Dig Dis Sci. 2018 Feb 1. pii: 10.1007/s10620-017-4897.
    PubMed     Abstract available


    January 2018
  128. BENBOW JH, Elam AD, Bossi KL, Massengill DL, et al
    Analysis of Plasma Tenascin-C in Post-HCV Cirrhosis: A Prospective Study.
    Dig Dis Sci. 2018 Jan 12. pii: 10.1007/s10620-017-4860.
    PubMed     Abstract available


  129. BURROUGHS TK, Wade JB, Ellwood MS, Fagan A, et al
    Effect of Post-Traumatic Stress Disorder on Cognitive Function and Covert Hepatic Encephalopathy Diagnosis in Cirrhotic Veterans.
    Dig Dis Sci. 2018 Jan 8. pii: 10.1007/s10620-017-4894.
    PubMed     Abstract available


    December 2017
  130. CHOE WH, Kim JH, Park JH, Kim HU, et al
    Endoscopic Submucosal Dissection of Early Gastric Cancer in Patients with Liver Cirrhosis.
    Dig Dis Sci. 2017 Dec 27. pii: 10.1007/s10620-017-4814.
    PubMed     Abstract available


  131. LIN M, Chang Y, Xie F, Shi Y, et al
    ASPP2 Inhibits the Profibrotic Effects of Transforming Growth Factor-beta1 in Hepatic Stellate Cells by Reducing Autophagy.
    Dig Dis Sci. 2017 Dec 2. pii: 10.1007/s10620-017-4816.
    PubMed     Abstract available


  132. SUK KT, Kim MY, Jeong SW, Jang JY, et al
    Impact of Bacterial Translocation on Hepatopulmonary Syndrome: A Prospective Observational Study.
    Dig Dis Sci. 2017 Dec 1. pii: 10.1007/s10620-017-4868.
    PubMed     Abstract available


    November 2017
  133. PRIVITERA G, Spadaro L, Marchisello S, Fede G, et al
    Abnormalities of Lipoprotein Levels in Liver Cirrhosis: Clinical Relevance.
    Dig Dis Sci. 2017 Nov 25. pii: 10.1007/s10620-017-4862.
    PubMed     Abstract available


  134. CULLARO G, Kim G, Pereira MR, Brown RS Jr, et al
    Ascites Neutrophil Gelatinase-Associated Lipocalin Identifies Spontaneous Bacterial Peritonitis and Predicts Mortality in Hospitalized Patients with Cirrhosis.
    Dig Dis Sci. 2017 Nov 2. doi: 10.1007/s10620-017-4804.
    PubMed     Abstract available


  135. TANEJA S, Borkakoty A, Rathi S, Kumar V, et al
    Assessment of Liver Fibrosis by Transient Elastography Should Be Done After Hemodialysis in End Stage Renal Disease Patients with Liver Disease.
    Dig Dis Sci. 2017;62:3186-3192.
    PubMed     Abstract available


    October 2017
  136. KRUGER AJ, Mumtaz K, Anaizi A, Modi RM, et al
    Cirrhosis Is Associated with Increased Mortality in Patients with Diverticulitis: A Nationwide Cross-Sectional Study.
    Dig Dis Sci. 2017 Oct 6. doi: 10.1007/s10620-017-4782.
    PubMed     Abstract available


    September 2017
  137. LUTZ P, Goeser F, Kaczmarek DJ, Schlabe S, et al
    Relative Ascites Polymorphonuclear Cell Count Indicates Bacterascites and Risk of Spontaneous Bacterial Peritonitis.
    Dig Dis Sci. 2017;62:2558-2568.
    PubMed     Abstract available


    August 2017
  138. XU H, Xiong J, Xu J, Li S, et al
    Mosapride Stabilizes Intestinal Microbiota to Reduce Bacterial Translocation and Endotoxemia in CCl4-Induced Cirrhotic Rats.
    Dig Dis Sci. 2017 Aug 16. doi: 10.1007/s10620-017-4704.
    PubMed     Abstract available


  139. LEE HW, Kim BK, Kim SU, Park JY, et al
    Prevalence and Predictors of Significant Fibrosis Among Subjects with Transient Elastography-Defined Nonalcoholic Fatty Liver Disease.
    Dig Dis Sci. 2017;62:2150-2158.
    PubMed     Abstract available


    June 2017
  140. AFSARI A, Lee E, Shokrani B, Boortalary T, et al
    Clinical and Pathological Risk Factors Associated with Liver Fibrosis and Steatosis in African-Americans with Chronic Hepatitis C.
    Dig Dis Sci. 2017 Jun 13. doi: 10.1007/s10620-017-4626.
    PubMed     Abstract available


    May 2017
  141. PANTHAM G, Post A, Venkat D, Einstadter D, et al
    A New Look at Precipitants of Overt Hepatic Encephalopathy in Cirrhosis.
    Dig Dis Sci. 2017 May 30. doi: 10.1007/s10620-017-4630.
    PubMed     Abstract available


  142. LENCI I, Bosa A, Milana M, Baiocchi L, et al
    Evidence of Spontaneous Post-transplant HCV Eradication in Two Failed DAA Treatments Awaiting Liver Transplantation.
    Dig Dis Sci. 2017 May 12. doi: 10.1007/s10620-017-4594.
    PubMed    


  143. TAVAKOLI H, Robinson A, Liu B, Bhuket T, et al
    Cirrhosis Patients with Nonalcoholic Steatohepatitis Are Significantly Less Likely to Receive Surveillance for Hepatocellular Carcinoma.
    Dig Dis Sci. 2017 May 4. doi: 10.1007/s10620-017-4595.
    PubMed     Abstract available


    April 2017
  144. DEVER JB, Ducom JH, Ma A, Nguyen J, et al
    Engagement in Care of High-Risk Hepatitis C Patients with Interferon-Free Direct-Acting Antiviral Therapies.
    Dig Dis Sci. 2017 Apr 4. doi: 10.1007/s10620-017-4548.
    PubMed     Abstract available


  145. YOSHIDA T, Akiba J, Matsui T, Nakamura K, et al
    Pigment Epithelium-Derived Factor (PEDF) Prevents Hepatic Fat Storage, Inflammation, and Fibrosis in Dietary Steatohepatitis of Mice.
    Dig Dis Sci. 2017 Apr 1. doi: 10.1007/s10620-017-4550.
    PubMed     Abstract available


    March 2017
  146. PATIDAR KR, Thacker LR, Wade JB, White MB, et al
    Symptom Domain Groups of the Patient-Reported Outcomes Measurement Information System Tools Independently Predict Hospitalizations and Re-hospitalizations in Cirrhosis.
    Dig Dis Sci. 2017 Mar 3. doi: 10.1007/s10620-017-4509.
    PubMed     Abstract available


  147. KALAFATELI M, Zisimopoulos K, Vourli G, Rigamonti C, et al
    Prognostic Models for Survival in Patients with Stable Cirrhosis: A Multicenter Cohort Study.
    Dig Dis Sci. 2017 Mar 1. doi: 10.1007/s10620-017-4504.
    PubMed     Abstract available


  148. O'LEARY JG, Wong F, Reddy KR, Garcia-Tsao G, et al
    Gender-Specific Differences in Baseline, Peak, and Delta Serum Creatinine: The NACSELD Experience.
    Dig Dis Sci. 2017;62:768-776.
    PubMed     Abstract available


    February 2017
  149. CAI CX, Buddha H, Castelino-Prabhu S, Zhang Z, et al
    Activation of Insulin-PI3K/Akt-p70S6K Pathway in Hepatic Stellate Cells Contributes to Fibrosis in Nonalcoholic Steatohepatitis.
    Dig Dis Sci. 2017 Feb 13. doi: 10.1007/s10620-017-4470.
    PubMed     Abstract available


  150. KIM G, Huh JH, Lee KJ, Kim MY, et al
    Relative Adrenal Insufficiency in Patients with Cirrhosis: A Systematic Review and Meta-Analysis.
    Dig Dis Sci. 2017 Feb 7. doi: 10.1007/s10620-017-4471.
    PubMed     Abstract available


    January 2017
  151. HUNG TH, Tseng CW, Tsai CC, Hsieh YH, et al
    Mortality Following Catheter Drainage Versus Thoracentesis in Cirrhotic Patients with Pleural Effusion.
    Dig Dis Sci. 2017 Jan 27. doi: 10.1007/s10620-017-4463.
    PubMed     Abstract available


  152. ZHAO D, Luo Y, Xia Y, Zhang JJ, et al
    MicroRNA-19b Expression in Human Biliary Atresia Specimens and Its Role in BA-Related Fibrosis.
    Dig Dis Sci. 2017 Jan 12. doi: 10.1007/s10620-016-4411.
    PubMed     Abstract available


  153. SRIDHAR A, Cwiak CA, Kaunitz AM, Allen RH, et al
    Contraceptive Considerations for Women with Gastrointestinal Disorders.
    Dig Dis Sci. 2017;62:54-63.
    PubMed     Abstract available


  154. DELLA-GUARDIA B, Evangelista AS, Felga GE, Marins LV, et al
    Diagnostic Accuracy of Transient Elastography for Detecting Liver Fibrosis After Liver Trannsplantation: A Specific Cut-Off Value Is Really Needed?
    Dig Dis Sci. 2017;62:264-272.
    PubMed     Abstract available


    December 2016
  155. NARDELLI S, Allampati S, Riggio O, Mullen KD, et al
    Hepatic Encephalopathy Is Associated with Persistent Learning Impairments Despite Adequate Medical Treatment: A Multicenter, International Study.
    Dig Dis Sci. 2016 Dec 30. doi: 10.1007/s10620-016-4425.
    PubMed     Abstract available


  156. KIM EJ, Yeon JE, Kwon OS, Lee HN, et al
    Rapid Alanine Aminotransferase Normalization with Entecavir and Hepatocellular Carcinoma in Hepatitis B Virus-Associated Cirrhosis.
    Dig Dis Sci. 2016 Dec 29. doi: 10.1007/s10620-016-4431.
    PubMed     Abstract available


  157. GOOSSENS N, Breguet R, De Vito C, Terraz S, et al
    Peribiliary Gland Dilatation in Cirrhosis: Relationship with Liver Failure and Stem Cell/Proliferation Markers.
    Dig Dis Sci. 2016 Dec 29. doi: 10.1007/s10620-016-4421.
    PubMed     Abstract available


    November 2016
  158. HWANG GL, Sze DY
    Survival in Cirrhotic Patients with High MELD Scores: The TIPping Point.
    Dig Dis Sci. 2016.
    PubMed    


  159. WALLING AM, Ahluwalia SC, Wenger NS, Booth M, et al
    Palliative Care Quality Indicators for Patients with End-Stage Liver Disease Due to Cirrhosis.
    Dig Dis Sci. 2016.
    PubMed     Abstract available


    October 2016
  160. TSOU YK, Liu CY, Fu KI, Lin CH, et al
    Endoscopic Submucosal Dissection of Superficial Esophageal Neoplasms Is Feasible and Not Riskier for Patients with Liver Cirrhosis.
    Dig Dis Sci. 2016.
    PubMed     Abstract available


    September 2016
  161. ALLEGRETTI AS, Ortiz G, Kalim S, Wibecan J, et al
    Siglec-7 as a Novel Biomarker to Predict Mortality in Decompensated Cirrhosis and Acute Kidney Injury.
    Dig Dis Sci. 2016.
    PubMed     Abstract available


  162. DONG T, Aronsohn A, Gautham Reddy K, Te HS, et al
    Rifaximin Decreases the Incidence and Severity of Acute Kidney Injury and Hepatorenal Syndrome in Cirrhosis.
    Dig Dis Sci. 2016.
    PubMed     Abstract available


  163. NATARAJAN Y, White DL, El-Serag HB, Ramsey D, et al
    Role of Non-hepatic Medical Comorbidity and Functional Limitations in Predicting Mortality in Patients with HCV.
    Dig Dis Sci. 2016.
    PubMed     Abstract available


    July 2016
  164. HOU F, Qi X, Guo X
    Effectiveness and Safety of Pleurodesis for Hepatic Hydrothorax: A Systematic Review and Meta-Analysis.
    Dig Dis Sci. 2016.
    PubMed     Abstract available


  165. MONTANO-LOZA AJ, Thandassery RB, Czaja AJ
    Targeting Hepatic Fibrosis in Autoimmune Hepatitis.
    Dig Dis Sci. 2016.
    PubMed     Abstract available


  166. KIM JH, Sinn DH, Kim K, Kang W, et al
    Primary Prophylaxis for Variceal Bleeding and the Improved Survival of Patients with Newly Diagnosed Hepatocellular Carcinoma.
    Dig Dis Sci. 2016.
    PubMed     Abstract available


  167. HEGADE VS, Khanna A, Walker LJ, Wong LL, et al
    Long-Term Fenofibrate Treatment in Primary Biliary Cholangitis Improves Biochemistry but Not the UK-PBC Risk Score.
    Dig Dis Sci. 2016.
    PubMed     Abstract available


    June 2016
  168. DE LUCA-JOHNSON J, Wangensteen KJ, Hanson J, Krawitt E, et al
    Natural History of Patients Presenting with Autoimmune Hepatitis and Coincident Nonalcoholic Fatty Liver Disease.
    Dig Dis Sci. 2016.
    PubMed     Abstract available


  169. THOMAS E, Schiff ER
    Early Detection of Steatohepatitis: Less Teeth NASHing and More Research?
    Dig Dis Sci. 2016.
    PubMed    


    April 2016
  170. MENDEL I, Yacov N, Shoham A, Ishai E, et al
    Treatment with Oxidized Phospholipids Directly Inhibits Nonalcoholic Steatohepatitis and Liver Fibrosis Without Affecting Steatosis.
    Dig Dis Sci. 2016.
    PubMed     Abstract available


  171. PECTASIDES E, Miksad R, Pyatibrat S, Srivastava A, et al
    Spontaneous Regression of Hepatocellular Carcinoma with Multiple Lung Metastases: A Case Report and Review of the Literature.
    Dig Dis Sci. 2016.
    PubMed     Abstract available


    March 2016
  172. VUPPALANCHI R, Chalasani N
    Screening Strategies for Nonalcoholic Steatohepatitis in High-Risk Individuals: Trimming Away the Fat.
    Dig Dis Sci. 2016.
    PubMed    


  173. NAGPAL SJ, Kabbany MN, Mohamad B, Lopez R, et al
    Portal Hypertension Complications Are Frequently the First Presentation of NAFLD in Patients Undergoing Liver Transplantation Evaluation.
    Dig Dis Sci. 2016.
    PubMed     Abstract available


  174. THOMSON M, Konerman MA, Choxi H, Lok AS, et al
    Primary Care Physician Perspectives on Hepatitis C Management in the Era of Direct-Acting Antiviral Therapy.
    Dig Dis Sci. 2016.
    PubMed     Abstract available


    February 2016
  175. CHEN L, Guo YZ, Li AD, Ma JJ, et al
    Knockdown of Astrocyte Elevated Gene-1 Inhibits Activation of Hepatic Stellate Cells.
    Dig Dis Sci. 2016.
    PubMed     Abstract available


    January 2016
  176. LANDIS CS, Ghabril M, Rustgi V, Di Bisceglie AM, et al
    Prospective Multicenter Observational Study of Overt Hepatic Encephalopathy.
    Dig Dis Sci. 2016.
    PubMed     Abstract available


    November 2015
  177. PETERSEN J, Heyne R, Mauss S, Schlaak J, et al
    Effectiveness and Safety of Tenofovir Disoproxil Fumarate in Chronic Hepatitis B: A 3-Year Prospective Field Practice Study in Germany.
    Dig Dis Sci. 2015.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Cirrhosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: